Glycobiology Advance Access originally published online on March 6, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Glycobiology, 2003, Vol. 13, No. 5 12G-13G
© 2003 Oxford University Press
GLYCO-FORUM SECTION |
Letter to the Glyco-Forum
HARE raising
Department of Biochemistry and Molecular Biology and the Oklahoma Center for Medical Glycobiology, the University of Oklahoma Health Sciences Center, Oklahoma City, OK 73190, USA
Received on February 12, 2003; accepted on February 12, 2003
| The first 10% of the full text of this article appears below. |
Smedsrod et al. (2003) have raised an issue regarding our study (Zhou et al., 2003
) on the human 190-kDa HA receptor for endocytosis (HARE), which appears in this issue of Glycobiology. We did not intend to slight their studies to characterize this HA receptor, which they term stabilin-2. However, we have a fundamentally different view about the type of the evidence needed to support a conclusion about the function of a newly discovered protein. We did not cite some conclusions from their previous studies because stating a conclusion in an article does not mean it is valid or fully supported by
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
E. N. Harris, S. V. Kyosseva, J. A. Weigel, and P. H. Weigel Expression, Processing, and Glycosaminoglycan Binding Activity of the Recombinant Human 315-kDa Hyaluronic Acid Receptor for Endocytosis (HARE) J. Biol. Chem., February 2, 2007; 282(5): 2785 - 2797. [Abstract] [Full Text] [PDF] |
||||
